Grafts and Graft Materials as Vascular Substitutes for Haemodialysis Access Construction

European Journal of Vascular and Endovascular Surgery

Volumn 32, Issue 2, 2006, Pages 203-211

  Berardinelli, L ^a,b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Haemodialysis; Prosthetic grafts; Vascular access

Indexed keywords

DACRON; LINEZOLID; POLITEF;

ARTERIOVENOUS SHUNT; ARTERY GRAFT; ARTERY STEAL SYNDROME; ARTICLE; BLOOD VESSEL GRAFT; BLOOD VESSEL PROSTHESIS; CENTRAL VENOUS CATHETERIZATION; CLINICAL TRIAL; EQUIPMENT DESIGN; FALSE ANEURYSM; GRAFT FAILURE; GRAFT INFECTION; GRAFT OCCLUSION; GRAFT PATENCY; GRAFT REJECTION; HEMODIALYSIS; HUMAN; INFECTION RESISTANCE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRIORITY JOURNAL; PROSTHESIS MATERIAL; SAPHENOUS VEIN GRAFT; SEROMA; SILICONE PROSTHESIS; VASCULAR ACCESS;

ARTERIES; ARTERIOVENOUS SHUNT, SURGICAL; BIOPROSTHESIS; BLOOD VESSEL PROSTHESIS; HUMANS; POLYTETRAFLUOROETHYLENE; PROSTHESIS DESIGN; PROSTHESIS-RELATED INFECTIONS; RENAL DIALYSIS; VEINS;

EID: 33748794289     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2006.01.001     Document Type: Article

References (77)

1. Xue L., and Greisler H. Biomaterials in the development and future of vascular grafts. J Vasc Surg 37 (2003) 472-480
2. Haimov M., Burrows L., Shanzer H., Neff M., Baez A., Kwun K., et al. Experience with arterial substitutes in the construction of vascular access for hemodialysis. J Cardiovasc Surg 21 (1980) 149
3. Bhandari S., Wilkinson A., and Sellars L. Saphenous vein forearm grafts and goretex thigh grafts as alternative forms of vascular access. Clin Nephrol 44 (1995) 325-328
4. Cimochowski G.E. Use of the spiral vein graft as an arterial substitute for secondary access. Am J Nephrol 11 (1991) 64-66
5. Ahmed N. Brachial artery to brachial vein preserved vein allograft fistulas for hemodialysis. J Cardiovasc Surg 17 (1976) 483-488
6. Vegeto A., Berardinelli L., and Malan E. Use of homologous vein grafts for chronic hemodialysis. J Cardiovasc Surg 18 5 (1977) 501-504
7. Piccone Jr. V.A. Preserved saphenous vein allografts for vascular access. Surg Gynecol Obstet 147 (1978) 385-390
8. Benedetto B., Lipkowitz G., Madden R., Kurbanov A., Hull D., Miller M., et al. Use of cryopreserved cadaveric vein allografts for hemodialysis access precludes kidney transplantation because of allosensitization. J Vasc Surg 34 (2001) 139-142
9. Heintjes R.J. The results of denatured homologous vein grafts as conduits for secondary hemodialysis access surgery. Eur J Vasc Endovasc Surg 9 (1995) 58-63
10. Bosman P.J., Blankestijn P.J., van der Graaf Y., Heintjes R.J., Koomans H.A., and Eikelboom B.C. A comparison between PTFE and denatured homologous vein grafts for hemodialysis access: a prospective randomized multicenter trial. The SMASH Study group. Study of graft materials in access for hemodialysis. Eur J Vasc Endovasc Surg 16 (1998) 126-132
11. Matsuura J.H., Rosenthal D., Wellons E.D., Castronovo C.S., and Fronk D. Hemodialysis graft infections treated with cryopreserved femoral vein. Cardiovasc Surg 10 (2002) 561-565
12. Bolton W.D., Cull D.L., Taylor S.M., Carsten C.G.I., Snyder B.A., Sullivan T.M., et al. The use of cryopreserved femoral vein grafts for hemodialysis access in patients at high risk for infection: a word of caution. J Vasc Surg 36 (2002) 464-468
13. Abu-dalu J., Urca U., Zonder H.B., and Rosenfeld J.B. Hemodialysis treatment by means of a cadaver arterial allografts. Arch Surg 105 (1972) 798-801
14. Dardik H., Ibrahim I.M., and Dardik I. Arteriovenous fistulas constructed with modified human umbilical cord vein graft. Arch Surg 111 (1976) 60-62
15. Wellington J.L. Umbilical vein grafts for vascular access in patients on long term hemodialysis. Can J Surg 24 (1981) 608-609
16. Jorgensen L., Bilde T., Kvist K.J., and Buchardt H.H.J. Human umbilical vein for vascular access in chronic hemodialysis. Scand J Urol Nephrol 19 (1985) 49-53
17. ®). Acta Chir Scand 152 (1986) 263-266
18. Brems J., Castaneda M., and Garvin P.J. A five year experience with the bovine heterograft for vascular access. Arch Surg 121 (1986) 941-944
19. Metha S. Statistical summary of clinical results of vascular procedures for hemodialysis. In: Sommer B.G., and Henry M.L. (Eds). Vascular access for hemodialysis, II (1991), WL Gore & Associates, Inc. and Precept Press, USA 145-157
20. Reese J.C., Esterl R., Lindsey L., et al. A prospective randomized comparison of bovine heterografts versus impra grafts for chronic hemodialysis. In: Henry M.L., and Ferguson R.M. (Eds). Vascular access for hemodialysis, III (1993), WL Gore & Associates, Inc. and Precept Press, USA 157-162
21. Oakes D., Gregg A., Sherck J., and Guest S.S. A new operation with inadequate Brescia fistulae for preservation of more proximal veins. J Vasc Surg 36 2 (2002) 346-350
22. Decurtinis M., Uhlschmid G.K., and Buchmann P. Bovine xenograft-a useful tissue for construction of arteriovenous fistulas for chronic hemodialysis. In: Kootstra G., and Jorning P.J.G. (Eds). Access surgery (1983), MPT Press Limited, Lancaster (England) 103-111
23. Kaplan M.S., Mirahmadi K.S., Wiener R.L., Gorman J.T., Dabirvaziri N., and Rosen S.M. Comparison of PTFE and bovine grafts for blood access in dialysis patients. Trans Am Soc Artif Intern Organs 22 (1976) 388
24. Wang S.S., and Chu S.H. Clinical use of omniflow vascular graft as arteriovenous bridging graft for hemodialysis. Artif Organs 20 12 (1996) 1278-1281
25. Katzman H.E., Glickman M.H., Schild A.F., Fujitani R.M., and Lawson J.H. Multicenter evaluation of the bovine mesenteric vein bioprostheses for hemodialysis access in patients with an earlier failed prosthetic graft. J Am Coll Surg 201 (2005) 223-230
26. Garvin P.J., Castaneda M.A., and Codd J.E. Etiology and management of bovine graft aneurysms. Arch Surg 117 (1982) 281-284
27. Matsuura J.H., Black K.S., Levitt A.B., Rosenthal D., Wellons E.D., Fallon M.T., et al. Cellular remodeling of depopulated bovine ureter used as an arteriovenous graft in the canine model. J Am Coll Surg 198 5 (2004) 778-783
28. Glickman M.H., Lawson J.H., Katzman H.E., Schild A.F., and Fujitani R.M. Challenges of hemodialysis access for high risk patients: impact of mesenteric bioprosthetic graft. J Vasc Access 4 (2003) 73-80
29. Widmer M.K., Aregger F., Stauffer E., Savolainen H., Heller G., Hakki H., et al. Intermediate outcome and risk factor assessment of bovine vascular heterograft used as AV-fistulas for hemodialysis access. Eur J Vasc Endovasc Surg 27 (2004) 660-665
30. Lin P.H., Brinkman W.T., Terramani T.T., and Lumsden A.B. Management of infected hemodialysis grafts using crypreserved human vein allografts. Am J Surg 184 (2002) 21-36
31. Huber T.S., Hirneise C.M., Lee W.A., Flynn T.C., and Seeger J.M. Outcome after autogenous brachial-axillary translocated superficial femoropopliteal vein hemodialysis access. J Vasc Surg 40 (2004) 311-318
32. Gradman W.S., Laub J., and Cohen W. Femoral vein transposition for arteriovenous hemodialysis access: improved patient selection and intraoperative measures reduce postoperative ischemia. J Vasc Surg 41 2 (2005) 279-284
33. Elliott M.P. Use of expanded PTFE grafts for vascular access in hemodialysis: laboratory and clinical evaluation. Am Surg 43 (1977) 455-459
34. Vroman L. Methods of investigating protein interaction on artificial and natural surfaces. Ann N Y Acad Sci 516 (1987) 300-305
35. Huber T.S., Carter J.W., Carter R.L., and Seeger J.M. Patency of autogenous and PTFE upper extremity arteriovenous hemodialysis accesses: a systematic review. J Vasc Surg 38 (2003) 1005-1011
36. Gibson K.D., Gillen D.L., Caps M.T., Kohler T.R., and Sherrard D.J. Vascular access survival and incidence of revisions: a comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States Renal Data System Dialysis Morbidity and Mortality Study. J Vasc Surg 34 (2001) 694-700
37. Hodges T.C., Fillinger M.F., Zwolak R.M., Walsh D.B., Bech F., and Cronenwett J.L. Longitudinal comparison of dialysis access methods: risk factors for failure. J Vasc Surg 26 (1997) 1009-1019
38. Lenz B.J. A three year follow-up on standard versus thin wall ePTFE grafts for hemodialysis. J Vasc Surg 28 (1998) 464-470
39. Almonacid P.J., Pallares E.C., Rodriguez A.Q., Valdes J.S., Rueda Orgaz J.A., and Polo J.R. Comparative study of use of diastat versus standard wall PTFE grafts in upper arm hemodialysis access. Ann Vasc Surg 14 6 (2000) 659-662
40. Sorom A.J., Hughes C.B., McCarty J.T., Jenson B.M., Prieto M., Pannenton J.M., et al. Prospective, randomized evaluation of a cuffed e-PTFE graft for hemodialysis vascular access. Surgery 132 2 (2002) 135-140
41. Reed W.P., and Sadler J.H. Experience with a needless vascular access device (hemasite) for hemodialysis. South Med J 77 (1984) 1501-1503
42. Santerre J.P., Labow R.S., Duguay D.G., Erfle D., and Adams G.A. Biodegradation evaluation of polyether and polyester-urethanes with oxidative and hydrolytic enzymes. J Biomed Mater Res 28 10 (1994) 1187-1199
43. Glickman M.H., Stokes G.K., Ross J.R., Schuman E.D., Sternberg W.C.3r., Lindbergh J.S., et al. Multicenter evaluation of a polytetrafluoroethylene vascular access graft as compared with the e-PTFE vascular access graft in hemodialysis applications. J Vasc Surg 34 3 (2001) 465-472
44. Wiese P., Blume J., Mueller H.J., Renner H., and Nonnast-Daniel A.B. Clinical and Doppler ultrasonography data of a polyurethane vascular access graft for hemodialysis: a prospective study. Nephrol Dial Transplant 18 7 (2003) 1397-1400
45. Nakagawa Y. Clinical trial of new PTFE vascular graft for hemodialysis: compared with expanded PTFE grafts. Artif Organs 19 (1995) 1227-1232
46. Allen R.D., Yuill E., Nankivell B.J., and Francis D.M. Australian multicenter evaluation of a new polyurethane vascular access graft. Aust NZ J Surg 66 11 (1996) 738-742
47. Friedman D.W., Orland P.J., and Greco R.S. Biomaterials: an historical prospective. In: Greco R.S. (Ed). Implantation biology: the host response and biomedical devices (1994), CRC press, Baco Raton (Fla) 1-12
48. Munda R., First M.R., Alexander J.W., Linnemann J., Fidler J.P., and Kittur D. PTFE graft survival in hemodialysis. JAMA 249 2 (1983) 219-222
49. Rizzuti R.P., Hale J.C., and Burkart T.E. Extended patency of e-PTFE grafts for vascular access using optimal configuration and revisions. Surg Gynecol Obstet 166 1 (1988) 23-27
50. Ruddle A.C., Lear P.A., and Mitchell D.C. The morbidity of secondary vascular access. A lifetime of intervention. Eur J Vasc Endovasc Surg 18 (1999) 30-34
51. Tellis V.A., and Veith F.J. Vascular access. In: Haimovici H. (Ed). Vascular surgery (1989), Appleton and Lange, Inc., East Norwalk, CT 806-825
52. Berardinelli L. Arteriovenous fistulas: different types and surgical techniques. In: Ronco C., and Levin N.W. (Eds). Hemodialysis vascular access and peritoneal dialysis access. Contrib Nephrol. Basel, Karger vol. 142 (2004), Contrib Nephrol, Basel, Karger 47-72
53. Greenstein S., Patel V., and Kim D. Surgical creation of fistulas and grafts. Tech Vasc Intervent Radiol 2 4 (1999) 174-178
54. Cull J.D., Cull D.L., Taylor S.M., Carsten C.G.3r., Snyder B.A., Youkey J.R., et al. Prosthetic thigh arteriovenous access: outcome with SVS/AAVS reporting standards. J Vasc Surg 39 2 (2004) 381-386
55. Gorski T.F. Lower-extremity saphenous vein transposition arteriovenous fistula: an alternative for hemodialysis access in AIDS patients. Am Surg 64 (1998) 338-340
56. Pierre-Paul D., Williams S., Lee T., and Gahtan V. Saphenous vein loop to femoral artery arteriovenous fistula: a practical alternative. Ann Vasc Surg 18 2 (2004) 223-227
57. Mandel S.R., and McDougal E.G. Popliteal artery to saphenous vein vascular access. Surg Gynecol Obstet 160 (1985) 358-359
58. Polo J.R., Sanabia J., Garcia-Sabrido J.L., Luno J., Menarguez C., and Echenagusia A. Brachial-jugular PTFE fistulas for hemodialysis. Am J Kidney Dis 16 5 (1990) 465-468
59. McCann R.L. Axillary grafts for difficult hemodialysis access. J Vasc Surg 24 (1996) 457-461
60. Rueckmann I., Berry C., Ouriel K., and Hoffart N. The synthetic axillofemoral graft for hemodialysis access. ANNA J 18 6 (1991) 567-571
61. McLafferty R.B., Taylor L.M.J., Moneta G.L., Yeager R.A., Edwards J.M., and Porter J.M. Upper extremity thromboembolism after axillary-axillary bypass grafting. Cardiovasc Surg 4 1 (1996) 111-113
62. Settmacher U., Heise M., and Sholz H. Das arterioarterielle Interponat als Dialysezugang. Gefasschirurgie 3 (1998) 11-13
63. Bünger C.M., Kröger J., Kock L., Henning A., Klar E., and Schareck W. Axillary-axillary interarterial chest loop conduit as an alternative for chronic hemodialysis access. J Vasc Surg 42 (2005) 290-295
64. El-Sabrout R.A., and Duncan J.M. Right atrial bypass grafting for central venous obstruction associated with dialysis access: another treatment option. J Vasc Surg 29 (1999) 472-478
65. Karb S.J., Hawxby A., and Burdick J.F. Axillorenal arteriovenous graft: a new approach for dialysis access. J Vasc Surg 40 (2004) 379-380
66. Mickley V. Stenosis and thrombosis in hemodialysis fistulae and grafts: the surgeon's point of view. Nephrol Dial Transplant 19 (2004) 309-311
67. Georgiadis G.S., Lazarides M.K., Lambidis C.D., Panagoutsos S.A., Kostakis A.G., Bastounis E.A., et al. Use of short PTFE segments (<6 cm) compares favorably with pure autologous repair in failing or thrombosed native arteriovenous fistulas. J Vasc Surg 41 1 (2005) 76-81
68. Ram S.J., Work J., Caldito G.C., Eason J.M., Pervez A., and Paulson W.D. A randomized controlled trial of blood flow and stenosis surveillance of hemodialysis grafts. Kidney Int 64 1 (2003) 272-280
69. Sloop G.D., Fallon K.B., and Zieske A.W. Atherosclerotic plaque-like lesions in synthetic arteriovenous grafts: implications for atherogenesis. Atherosclerosis 160 1 (2002) 133-139
70. Andrew J., and Gibbons C.P. Vascular access for hemodialysis. In: Beard J.D., and Murray S. (Eds). Pathways of care in vascular surgery (2002), tfm Publishing Ltd, Shrewsbury, UK 241-254
71. Tordoir J.H.M., Dammers R., and Van der Sande F.M. Upper arm extremity ischemia and hemodialysis vascular access. Eur J Vasc Endovasc Surg 27 (2004) 1-5
72. Levin M.P. The hemodialysis patient and hand amputation. Am J Nephrol 21 6 (2001) 498-501
73. Bonomo R.A., Rice D., Whalen C., Linn D., Eckstein E., and Shalaes D.M. Risk factors associated with permanent access-site infections in chronic hemodialysis patients. Infect Control Hosp Epidemiol 18 11 (1997) 757-761
74. Pastan S., Soucie M.J., and McClellan W.M. Vascular access and increased risk of death among hemodialysis patients. Kidney Int 62 2 (2002) 620-626
75. Sharpe J.N., Shively E.H., and Polk Jr. H.C. Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus Aureus. Am J Surg 189 (2005) 425-428
76. Minga T.E., Flanagan K.H., and Allon M. Clinical consequences of infected arteriovenous grafts in hemodialysis patients. Am J Kidney Dis 38 5 (2001) 975-978
77. Berardinelli L. Dialysis access related infections: treatments and early/long term results. Cardionephrology 9 (2005) 341-345 [Ed. Bios, Castrolibero]